Loading...
XLON
IUG
Market cap56mUSD
Feb 18, Last price  
12.88GBP
Name

Intelligent Ultrasound Group PLC

Chart & performance

D1W1MN
XLON:IUG chart
P/E
—
P/S
3.77
EPS
—
Div yield, %
—
Shrs. gr., 5y
27.97%
Rev. gr., 5y
16.03%
Revenues
11m
+10.62%
362,000731,0001,352,0001,804,1462,207,6333,286,1474,180,6305,313,1645,915,6715,170,0007,596,00010,100,00011,173,000
Net income
-3m
L-13.47%
-295,000-156,000-329,000-1,488,920-1,630,097-2,414,145-5,418,119-3,417,464-4,222,418-3,306,000-3,610,000-2,984,000-2,582,000
CFO
-2m
L+150.15%
-207,000-396,000167,000-1,405,534-950,768-2,187,494-2,195,656-2,591,779-3,293,202-2,260,000-1,819,000-684,000-1,711,000

Notes

No notes on this company yet
Write a private note on this company, for your eyes only

Profile

Intelligent Ultrasound Group plc is a UK-based medical technology firm that develops, markets, and distributes both advanced clinical ultrasound software and medical training simulators across the United Kingdom, North America, and other international markets. The company's innovative AI-powered ultrasound software solutions include ScanNav Assist, which provides real-time image analysis for women's health examinations; ScanNav Anatomy Peripheral Nerve Block (PNB), designed to automatically identify crucial anatomical structures during PNB procedures; and ScanNav Detect, which aids in the automatic recognition of anomalies during general medical ultrasound scans. Additionally, they offer ScanNav HealthCheck, a product facilitating home-based ultrasound scanning. For medical education and skill development, Intelligent Ultrasound provides a comprehensive range of simulators. These include ScanTrainer, an educational platform that leverages actual patient scans for training in obstetrics, gynecology, general medicine, and emergency medicine; ScanNav Anatomy PNB Trainer, focused on teaching ultrasound-guided needling techniques; BodyWorks Eve, an ultra-realistic female patient simulator for interactive point-of-care ultrasound scenario training; and NeedleTrainer, an augmented reality solution for safe and realistic ultrasound-guided needling practice. Further offerings in their simulation portfolio comprise BabyWorks, a baby manikin for pediatric and neonatal point-of-care ultrasound and echocardiography; HeartWorks, a highly realistic simulator for echocardiography training; BodyWorks, a high-fidelity simulator utilized in critical, intensive, and emergency care settings; and ORSIM, a virtual environment designed for mastering advanced bronchoscopy skills. Founded in 2004, the company was formerly known as MedaPhor Group plc before adopting its current name, Intelligent Ultrasound Group plc, in January 2019. Its headquarters are located in Cardiff, United Kingdom.

Related entities

Parent

Key people

Riccardo Pigliucci
Non-Executive Chairman of the Board · since 2014
Ian George Whittaker
Chief Operating Officer, Executive Director · since 2016
Chief Executive Officer, Executive Director · since 2014
Helen Mary Kinsey Jones
Group Finance Director, Executive Director · since 2020
Nicholas Sleep
Chief Technology Officer, Executive Director · since 2014
Nazar Najib Amso
Non-Executive Director · since 2014
Nicholas Avis
Non-Executive Director · since 2014
Andrew Charles Barker
Non-Executive Director · since 2017
Non-Executive Director · since 2014
IPO date
Aug 27, 2014
Employees
65
Domiciled in
GB
Incorporated in
GB
Headquarters & legal address
FLOOR 6A, HODGE HOUSE
114-116 ST MARY STREET
CARDIFF, CRF CF10 1DY
GB
Previous name
MEDAPHOR GROUP PLC
Previous name
MEDAPHOR MEDICAL SIMULATORS PLC

Valuation

Title
GBP in thousands, except ratios and share amounts
FYFYFYFYFYFYFYFY
2023‑122022‑122021‑122020‑122019‑122018‑122017‑122016‑12
Income
Revenues
Cost of revenue
Unusual Expense (Income)
NOPBT
NOPBT Margin
Operating Taxes
Tax Rate
NOPAT
Net income
Dividends
Dividend yield
Proceeds from repurchase of equity
BB yield
Debt
Debt current
Long-term debt
Deferred revenue
Other long-term liabilities
Net debt
Cash flow
Cash from operating activities
CAPEX
Cash from investing activities
Cash from financing activities
FCF
Balance
Cash
Long term investments
Excess cash
Stockholders' equity
Invested Capital
ROIC
ROCE
EV
Common stock shares outstanding
Price
Market cap
EV
EBITDA
EV/EBITDA
Interest
Interest/NOPBT